Agriculture
(a)
biological assets ;
(b)
(c)
government grants covered by paragraphs 34 and 35 .
(a)
land related to agricultural activity (see Ind AS 16 Property, Plant and Equipment and Ind AS 40 Investment Property );
(b)
bearer plants related to agricultural activity (see Ind AS 16). However, this Standard applies to the produce on those bearer plants.
(c)
government grants related to bearer plants (see Ind AS 20 Accounting for Government Grants and Disclosure of Government Assistance ).
(d)
intangible assets related to agricultural activity (See Ind AS 38 Intangible Assets ).
(e)
1 right-of-use assets arising from a lease of land related to agricultural activity (see Ind AS 116, Leases ).
(a)
is used in the production or supply of agricultural produce;
(b)
is expected to bear produce for more than one period; and
(c)
has a remote likelihood of being sold as agricultural produce, except for incidental scrap sales.
(a)
plants cultivated to be harvested as agricultural produce (for example, trees grown for use as lumber);
(b)
plants cultivated to produce agricultural produce when there is more than a remote likelihood that the entity will also harvest and sell the plant as agricultural produce, other than as incidental scrap sales (for example, trees that are cultivated both for their fruit and their lumber); and
(c)
annual crops (for example, maize and wheat).
(a)
Capability to change Living animals and plants are capable of biological transformation;
(b)
Management of change Management facilitates biological transformation by enhancing, or at least stabilising, conditions necessary for the process to take place (for example, nutrient levels, moisture, temperature, fertility, and light). Such management distinguishes agricultural activity from other activities. For example, harvesting from unmanaged sources (such as ocean fishing and deforestation) is not agricultural activity; and
(c)
Measurement of change The change in quality (for example, genetic merit, density, ripeness, fat cover, protein content, and fibre strength) or quantity (for example, progeny, weight, cubic metres, fibre length or diameter, and number of buds) brought about by biological transformation or harvest is measured and monitored as a routine management function.
(a)
asset changes through (i) growth (an increase in quantity or improvement in quality of an animal or plant), (ii) degeneration (a decrease in the quantity or deterioration in quality of an animal or plant), or (iii) procreation (creation of additional living animals or plants); or
(b)
production of agricultural produce such as latex, tea leaf, wool, and milk.
(a)
the entity controls the asset as a result of past events;
(b)
it is probable that future economic benefits associated with the asset will flow to the entity; and
(c)
the fair value or cost of the asset can be measured reliably.
(a)
little biological transformation has taken place since initial cost incurrence (for example, for seedlings planted immediately prior to the end of a reporting period or newly acquired livestock); or
(b)
the impact of the biological transformation on price is not expected to be material (for example, for the initial growth in a 30-year pine plantation production cycle).
(a)
the nature of its activities involving each group of biological assets; and
(b)
non-financial measures or estimates of the physical quantities of:
(i)
each group of the entity’s biological assets at the end of the period; and
(ii)
output of agricultural produce during the period.
(a)
the existence and carrying amounts of biological
(b)
the amount of commitments for the development or
(c)
financial risk management strategies related to
(a)
the gain or loss arising from changes in fair value less costs to sell;
(b)
increases due to purchases;
(c)
decreases attributable to sales and biological assets classified as held for sale (or included in a disposal group that is classified as held for sale) in accordance with Ind AS 105 ;
(d)
decreases due to harvest;
(e)
increases resulting from business combinations;
(f)
net exchange differences arising on the translation of financial statements into a different presentation currency, and on the translation of a foreign operation into the presentation currency of the reporting entity; and
(g)
other changes.
(a)
a description of the biological assets;
(b)
an explanation of why fair value cannot be measured
(c)
if possible, the range of estimates within which fair
(d)
the depreciation method used;
(e)
the useful lives or the depreciation rates used; and
(f)
the gross carrying amount and the accumulated
(a)
impairment losses;
(b)
reversals of impairment losses; and
(c)
depreciation.
(a)
a description of the biological assets;
(b)
an explanation of why fair value has become reliably
(c)
the effect of the change.
(a)
the nature and extent of government grants recognised in the financial statements;
(b)
unfulfilled conditions and other contingencies attaching to government grants; and
(c)
significant decreases expected in the level of government grants.
(i)
Paragraph 9
(ii)
Paragraph 14
(iii)
Paragraphs 17-21
(iv)
Paragraph 23
(v)
Paragraph 39
(vi)
Paragraphs 47-48
Notes, amendments & references (7)
# This Ind AS was notified vide G.S.R. 111(E) dated 16 t h February, 2015 and was amended vide Notification No. G.S.R. 273(E) dated 30 t h March, 2019 and G.S.R. 255(E) dated 23 rd March, 2022.
1 Inserted vide Notification No. G.S.R. 273(E) dated 30 t h March, 2019.
2 Substituted vide Notification No. G.S.R. 255(E) dated 23 rd March, 2022.
3 Heading and paragraphs 58-64 inserted vide Notification No. G.S.R. 273(E) dated 30 t h March, 2019.
* Refer Appendix 1
4 Inserted vide Notification No. G.S.R. 255(E) dated 23 rd March, 2022.
5 Inserted vide Notification No. G.S.R. 273(E) dated 30 t h March, 2019.